{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:10:39Z","timestamp":1790313039005,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02999-1","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:05:59Z","timestamp":1758881159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["HEG1 promotes gastric cancer progression by stabilizing AKT1 and is functionally regulated by the deubiquitinase USP48"],"prefix":"10.1186","volume":"30","author":[{"given":"Yajun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouhai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-Man","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"3","key":"2999_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534\u201342.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"2999_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s40001-024-02110-0","volume":"29","author":"G Zheng","year":"2024","unstructured":"Zheng G, Liu X, Abuduwufuer A, Yu H, He S, Ji W. Poria cocos inhibits the invasion, migration, and epithelial-mesenchymal transition of gastric cancer cells by inducing ferroptosis in cells. Eur J Med Res. 2024;29(1):531.","journal-title":"Eur J Med Res"},{"key":"2999_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cancergen.2023.12.006","volume":"282\u2013283","author":"A Ghorbani","year":"2024","unstructured":"Ghorbani A, Hosseinie F, Khorshid Sokhangouy S, Islampanah M, Khojasteh-Leylakoohi F, Maftooh M, et al. The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancer. Cancer Genet. 2024;282\u2013283:14\u201326.","journal-title":"Cancer Genet"},{"key":"2999_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114012","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21114012.","journal-title":"Int J Mol Sci"},{"key":"2999_CR5","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429322420241112051105","volume":"17","author":"S Fatima","year":"2024","unstructured":"Fatima S, Song Y, Zhang Z, Fu Y, Zhao R, Malik K, et al. Exploring the pharmacological mechanisms of P-hydroxylcinnamaldehyde for treating gastric cancer: a pharmacological perspective with experimental confirmation. Curr Mol Pharmacol. 2024;17: e18761429322420.","journal-title":"Curr Mol Pharmacol"},{"issue":"15","key":"2999_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCULATIONAHA.123.064735","volume":"149","author":"IA Tamargo","year":"2024","unstructured":"Tamargo IA, Baek KI, Xu C, Kang DW, Kim Y, Andueza A, et al. HEG1 protects against atherosclerosis by regulating stable flow-induced KLF2\/4 expression in endothelial cells. Circulation. 2024;149(15):1183\u2013201.","journal-title":"Circulation"},{"issue":"3","key":"2999_CR7","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1002\/cam4.5081","volume":"12","author":"X Zou","year":"2023","unstructured":"Zou X, Zhang Y, Wang N, Shi J, Li Q, Hao W, et al. HEG1 as a novel potential biomarker for the prognosis of lung adenocarcinoma. Cancer Med. 2023;12(3):3288\u201398.","journal-title":"Cancer Med"},{"issue":"14","key":"2999_CR8","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1042\/CS20190225","volume":"133","author":"YR Zhao","year":"2019","unstructured":"Zhao YR, Wang JL, Xu C, Li YM, Sun B, Yang LY. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt\/beta-catenin signaling. Clin Sci (Lond). 2019;133(14):1645\u201362.","journal-title":"Clin Sci (Lond)"},{"key":"2999_CR9","doi-asserted-by":"publisher","first-page":"45768","DOI":"10.1038\/srep45768","volume":"7","author":"S Tsuji","year":"2017","unstructured":"Tsuji S, Washimi K, Kageyama T, Yamashita M, Yoshihara M, Matsuura R, et al. HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma. Sci Rep. 2017;7:45768.","journal-title":"Sci Rep"},{"issue":"3","key":"2999_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/his.14783","volume":"82","author":"A Churg","year":"2023","unstructured":"Churg A, Naso JR. Hypothesis: HEG1 and claudin-4 staining will allow a diagnosis of epithelioid and biphasic mesothelioma versus non-small-cell lung carcinoma with only two stains in most cases. Histopathology. 2023;82(3):385\u201392.","journal-title":"Histopathology"},{"key":"2999_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11113001","author":"M Islam","year":"2023","unstructured":"Islam M, Jones S, Ellis I. Role of Akt\/protein kinase B in cancer metastasis. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11113001.","journal-title":"Biomedicines"},{"key":"2999_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2021.06.019","volume":"85","author":"L Yu","year":"2022","unstructured":"Yu L, Wei J, Liu P. Attacking the PI3K\/Akt\/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Semin Cancer Biol. 2022;85:69\u201394.","journal-title":"Semin Cancer Biol"},{"key":"2999_CR13","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429318398240918063450","volume":"17","author":"X Zhang","year":"2024","unstructured":"Zhang X, Jin M, Yao X, Liu J, Yang Y, Huang J, et al. Upregulation of LncRNA WT1-AS inhibits tumor growth and promotes autophagy in gastric cancer via suppression of PI3K\/Akt\/mTOR pathway. Curr Mol Pharmacol. 2024;17: e18761429318398.","journal-title":"Curr Mol Pharmacol"},{"issue":"2","key":"2999_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.32604\/or.2023.043807","volume":"32","author":"T Li","year":"2023","unstructured":"Li T, Zhong W, Yang L, Zhao Z, Wang LI, Liu C, et al. GIPC1 promotes tumor growth and migration in gastric cancer via activating PDGFR\/PI3K\/AKT signaling. Oncol Res. 2023;32(2):361\u201371.","journal-title":"Oncol Res"},{"issue":"10","key":"2999_CR15","doi-asserted-by":"publisher","first-page":"860","DOI":"10.2174\/1568026623666230111154537","volume":"23","author":"P Manogaran","year":"2023","unstructured":"Manogaran P, Beeraka NM, Paulraj RS, Sathiyachandran P, Thammaiappa M. Impediment of cancer by dietary plant-derived alkaloids through oxidative stress: implications of PI3K\/AKT pathway in apoptosis, autophagy, and ferroptosis. Curr Top Med Chem. 2023;23(10):860\u201377.","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"2999_CR16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1186\/s12967-023-04651-0","volume":"21","author":"J Liu","year":"2023","unstructured":"Liu J, Gu X, Guan Z, Huang D, Xing H, Zheng L. Role of m6A modification in regulating the PI3K\/AKT signaling pathway in cancer. J Transl Med. 2023;21(1):774.","journal-title":"J Transl Med"},{"issue":"5","key":"2999_CR17","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1080\/15548627.2023.2287930","volume":"20","author":"Y Wang","year":"2024","unstructured":"Wang Y, Ping Z, Gao H, Liu Z, Xv Q, Jiang X, et al. LYC inhibits the AKT signaling pathway to activate autophagy and ameliorate TGFB-induced renal fibrosis. Autophagy. 2024;20(5):1114\u201333.","journal-title":"Autophagy"},{"issue":"5","key":"2999_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1096\/fba.2020-00141","volume":"3","author":"MA Lopez-Ramirez","year":"2021","unstructured":"Lopez-Ramirez MA, McCurdy S, Li W, Haynes MK, Hale P, Francisco K, et al. Inhibition of the HEG1-KRIT1 interaction increases KLF4 and KLF2 expression in endothelial cells. FASEB Bioadv. 2021;3(5):334\u201355.","journal-title":"FASEB Bioadv"},{"issue":"2","key":"2999_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.chmed.2020.08.003","volume":"13","author":"YX Yao","year":"2021","unstructured":"Yao YX, Xu YL, Liu BW, Yang H, Li SY, Zhazo LL, et al. Identification and verification of effective components of Huanghuai for dysfunctional uterine bleeding based on network pharmacology and molecular docking. Chin Herbal Med. 2021;13(2):177\u201388.","journal-title":"Chin Herbal Med"},{"issue":"8","key":"2999_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, et al. Ualcan: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649\u201358.","journal-title":"Neoplasia"},{"issue":"21","key":"2999_CR21","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"key":"2999_CR22","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkm882","volume":"36","author":"M Kanehisa","year":"2008","unstructured":"Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, et al. KEGG for linking genomes to life and the environment. Nucl Acid Res. 2008;36:D480-4.","journal-title":"Nucl Acid Res"},{"issue":"3","key":"2999_CR23","first-page":"100625","volume":"5","author":"B Gyorffy","year":"2024","unstructured":"Gyorffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation (Camb). 2024;5(3):100625.","journal-title":"Innovation (Camb)"},{"issue":"13","key":"2999_CR24","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/pmic.201100504","volume":"12","author":"A Asplund","year":"2012","unstructured":"Asplund A, Edqvist PH, Schwenk JM, Ponten F. Antibodies for profiling the human proteome-the Human Protein Atlas as a resource for cancer research. Proteomics. 2012;12(13):2067\u201377.","journal-title":"Proteomics"},{"issue":"D1","key":"2999_CR25","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956\u201363.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2999_CR26","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ccell.2020.10.008","volume":"38","author":"W Zhao","year":"2020","unstructured":"Zhao W, Li J, Chen MM, Luo Y, Ju Z, Nesser NK, et al. Large-scale characterization of drug responses of clinically relevant proteins in cancer cell lines. Cancer Cell. 2020;38(6):829-43 e4.","journal-title":"Cancer Cell"},{"issue":"21","key":"2999_CR27","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","volume":"34","author":"CJ Liu","year":"2018","unstructured":"Liu CJ, Hu FF, Xia MX, Han L, Zhang Q, Guo AY. GSCALite: a web server for gene set cancer analysis. Bioinformatics. 2018;34(21):3771\u20132.","journal-title":"Bioinformatics"},{"issue":"4","key":"2999_CR28","doi-asserted-by":"publisher","first-page":"615","DOI":"10.32604\/or.2023.029698","volume":"31","author":"J He","year":"2023","unstructured":"He J, Zeng F, Jin XI, Liang L, Gao M, Li W, et al. Ywhah activates the HMGA1\/PI3K\/AKT\/mTOR signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells. Oncol Res. 2023;31(4):615\u201330.","journal-title":"Oncol Res"},{"issue":"7","key":"2999_CR29","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1158\/0008-5472.CAN-22-1812","volume":"83","author":"Y Ren","year":"2023","unstructured":"Ren Y, Feng M, Hao X, Liu X, Li J, Li P, et al. Usp48 stabilizes Gasdermin E to promote pyroptosis in cancer. Cancer Res. 2023;83(7):1074\u201393.","journal-title":"Cancer Res"},{"issue":"8","key":"2999_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00018-022-04489-7","volume":"79","author":"P Jantaree","year":"2022","unstructured":"Jantaree P, Chaithongyot S, Sokolova O, Naumann M. USP48 and A20 synergistically promote cell survival in Helicobacter pylori infection. Cell Mol Life Sci. 2022;79(8):461.","journal-title":"Cell Mol Life Sci"},{"issue":"14","key":"2999_CR31","doi-asserted-by":"publisher","first-page":"3822","DOI":"10.1158\/0008-5472.CAN-20-4163","volume":"81","author":"L Du","year":"2021","unstructured":"Du L, Li Y, Kang M, Feng M, Ren Y, Dai H, et al. Usp48 is upregulated by Mettl14 to attenuate hepatocellular carcinoma via regulating SIRT6 stabilization. Cancer Res. 2021;81(14):3822\u201334.","journal-title":"Cancer Res"},{"key":"2999_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168508","author":"AM Antao","year":"2021","unstructured":"Antao AM, Kaushal K, Das S, Singh V, Suresh B, Kim KS, et al. USP48 governs cell cycle progression by regulating the protein level of Aurora B. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22168508.","journal-title":"Int J Mol Sci"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02999-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02999-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02999-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:06:00Z","timestamp":1758881160000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02999-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2999"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02999-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol of the present study was established according to the ethical guidelines of the Helsinki Declaration and was approved by the Human Ethics Committee of The First Affiliated Hospital of University of Science and Technology of China West District. Written informed consent was obtained from individual participants or the guardians of participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for the publication of this study, including the use of patient-derived tissue samples, was obtained from all participants or their legal guardians prior to sample collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"872"}}